In the present thesis called "The modern analytical methods for detection of aminoacids asociated with malignant prostate tumours" sarcosine has been studied as a potential tumor marker which has significance for the diagnosis of aggressive forms of prostate cancer. The effect of addition of sarcosine prostate line PC3 has been also studied as well. Next studied area were the the interactions with amino acid sarcosine, sodium chloride, uric acid and uracil. We have primarily focused also on the development of methods for the detection of sarcosine in urine samples of patients with Cap and prostate cells
Sarcosine, an isomer of L-alanine, has been proposed as a prostate cancer progression biomarker [1]....
There has been recent interest in metabolite concentrations present in urine for noninvasive disease...
A fully automated, non invasive, rapid and high-throughput method for the direct determination of sa...
Prostate carcinoma is one of the most frequent cancer diseases of maturated men. Diagnose of this ca...
Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of cancer o...
The following diploma thesis titled Effects of sarcosine on calmodulin-dependent intracellular signa...
The current prostate cancer (PCa) diagnosis, based on the blood prostate-specific antigen (PSA) leve...
Sarcosine, N-methyl glycine, could be used as a biomarker for the diagnosis of prostate cancer. It e...
Prostate cancer is the leading type of cancer diagnosed in men. Serum prostate-specific antigen leve...
The aim of this pilot study is to evaluate sarcosine, uracil, and kynurenic acid in urine as potenti...
Prostate cancer (PC) – refers to important and serious problems in urology. In Ukraine, PC ranks fou...
Current prostate cancer (PCa) diagnosis based on prostate-specific antigen (PSA) has been gradually ...
Shortly after sarcosine was delineated as a potential biomarker for prostate cancer in 2009, a varie...
Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of cancer of...
An enzyme-coupled colorimetric assay for quantification of urinary sarcosine was developed. The prop...
Sarcosine, an isomer of L-alanine, has been proposed as a prostate cancer progression biomarker [1]....
There has been recent interest in metabolite concentrations present in urine for noninvasive disease...
A fully automated, non invasive, rapid and high-throughput method for the direct determination of sa...
Prostate carcinoma is one of the most frequent cancer diseases of maturated men. Diagnose of this ca...
Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of cancer o...
The following diploma thesis titled Effects of sarcosine on calmodulin-dependent intracellular signa...
The current prostate cancer (PCa) diagnosis, based on the blood prostate-specific antigen (PSA) leve...
Sarcosine, N-methyl glycine, could be used as a biomarker for the diagnosis of prostate cancer. It e...
Prostate cancer is the leading type of cancer diagnosed in men. Serum prostate-specific antigen leve...
The aim of this pilot study is to evaluate sarcosine, uracil, and kynurenic acid in urine as potenti...
Prostate cancer (PC) – refers to important and serious problems in urology. In Ukraine, PC ranks fou...
Current prostate cancer (PCa) diagnosis based on prostate-specific antigen (PSA) has been gradually ...
Shortly after sarcosine was delineated as a potential biomarker for prostate cancer in 2009, a varie...
Prostate cancer (CaP) is the most common type of tumour disease in men. Early diagnosis of cancer of...
An enzyme-coupled colorimetric assay for quantification of urinary sarcosine was developed. The prop...
Sarcosine, an isomer of L-alanine, has been proposed as a prostate cancer progression biomarker [1]....
There has been recent interest in metabolite concentrations present in urine for noninvasive disease...
A fully automated, non invasive, rapid and high-throughput method for the direct determination of sa...